(JULY 3, 2024) Sunil (“Sunny”) Eappen, M.D., M.B.A., president and CEO of the University of Vermont Health Network and clinical professor of anesthesiology at the Larner College of Medicine, commented in a VTDigger article on the selection of Vermont to take part in a federal health care reform model known as AHEAD.

5 teams of UVM Larner College of Medicine Class of 2027 medical students, along with 5 teams from Geisel School of Medicine at Dartmouth College, and Vermont Law and Graduate School, have been selected to participate as 2024–25 Schweitzer Fellows through the New Hampshire/Vermont (NH/VT) Schweitzer Fellows Program.

Using a novel therapy discovered in the Cunniff Lab at the University of Vermont Cancer Center, RS Oncology, a privately held biopharmaceutical company focusing on novel treatments for rare and aggressive cancers, presented positive results from its Phase 1 study in patients with Malignant Pleural Mesothelioma (MPM) with Malignant Pleural Effusion (MPE) or MPE associated with other solid tumors at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting.

Undernourished children are more vulnerable to pathogens and more likely to die from vaccine-preventable infectious disease, even when vaccinated. Research by Benjamin Lee, M.D., associate professor of pediatrics, points to gut health as a contributing factor.